+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Contraceptive Pills Market By Pill Type (Progestin Pills & Combination Pills), By Category (Generic & Branded), By Sales Channel, By Region (North America, Europe, APAC, South America & MEA), Competition, Forecast & Opportunities, 2024

  • ID: 4773064
  • Report
  • Region: Global, Asia Pacific, Europe, North America, United States
  • 112 pages
  • TechSci Research
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

1 of 3
Global Contraceptive Pills Market was Valued at $6 Billion in 2018 Expected to Witness Growth at a CAGR of 6.6%

FEATURED COMPANIES

  • Allergan plc
  • Bayer AG
  • Church & Dwight Co., Inc.
  • Johnson & Johnson Limited
  • Merck & Co., Inc.
  • Mylan N.V.
  • MORE
The global contraceptive pills market was valued at $ 6 billion in 2018 and is expected to witness growth at a CAGR of 6.6% during 2019-2024, to reach $ 8.8 billion by 2024, owing to the rising awareness regarding contraception methods in emerging countries. Contraceptive pill is one of the most commonly used forms of reversible birth control. This form of birth control suppresses ovulation (the monthly release of an egg from the ovaries) by the combined actions of the hormones estrogen and progestin, thereby drastically reducing the chances of becoming pregnant.

Unwanted pregnancies are on the rise, globally. Government bodies of various countries are taking various measures like promoting the use of contraceptive pills to prevent this unwanted growth. Given the widespread implications of unwanted pregnancies, the market for contraceptive pills is expected to experience a surge during the forecast period. However, factors like time constraints associated with the intake of emergency contraceptive pills and their side-effects, are expected to hamper the sales of emergency contraceptive pills during forecast period.

In terms of category, the contraceptive pills market is segmented into generic and branded, of which branded drug category accounted for a significant share in the global contraceptive pills market in 2018 and the segment is anticipated to maintain its dominance during forecast period as well. The growth of the branded drug category is backed by the widespread adoption of branded contraceptives due to easy availability and more safety in comparison to generic drugs.

Regionally, North America accounted for a significant share of around 40% of the global contraceptive pills market in 2018. The growth of the North American contraceptive pills market is majorly attributable to the strong presence of key market players, higher awareness about sexual health and large number of unintended pregnancies in the region. Among countries, the US contraceptive pills market accounted for majority share in the North American contraceptive pills market in 2018 and is anticipated to maintain its dominance during forecast period as well.

The global contraceptive pills market is fragmented in nature due to presence of several generic drugs. Approval & commercialization of various products and expanding geographical reach are major strategies adopted by industry participants to enhance their market share. Some of the major players operating in the global contraceptive pills market are Bayer AG, Allergan, Lupin Pharmaceuticals, Pfizer Inc., Teva Pharmaceuticals Industries Limited. among others.

Years considered for this report:
  • Historical Years: 2014-2017
  • Base Year: 2018
  • Estimated Year: 2019
  • Forecast Period: 2020–2024
Objective of the Study:
  • To analyze and forecast the global contraceptive pills market size
  • To classify and forecast the global contraceptive pills market based on pill type, by category, by sales channel and regional distribution
  • To identify drivers and challenges for the global contraceptive pills market
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the global contraceptive pills market
  • To conduct pricing analysis for the global contraceptive pills market
  • To identify and analyze the profile of leading players involved in the global contraceptive pills market
Some of the leading players in the global contraceptive pills market are Agile Therapeutics Inc., Bayer AG, Allergan plc, Lupin Pharmaceuticals Inc., Pfizer Inc., Teva Pharmaceutical Limited., Merck & Co. Inc., Mylan N.V., Novartis International AG, etc.

Both primary as well as exhaustive secondary research were performed for this study. Initially, a list of manufacturers across the globe were sourced. Subsequently, primary research surveys were conducted with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, the research could include the manufacturers which could not be identified due to the limitations of secondary research. The service offerings, Sales Channels and presence of all major manufacturers across the globe were analysed.

The researchers calculated the global contraceptive pills market size by using a bottom-up approach, wherein data for various application across various end-user segments was recorded and forecast for the future years. The researchers sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied.

Key Target Audience:
  • Global contraceptive pill manufacturers, suppliers, distributors and stakeholders
  • Potential investors
  • Organizations, forums and alliances related to the contraceptive pills market
  • Research organizations and consulting companies
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers and partners, end-users, etc. besides allowing them in strategizing investments and capitalizing on the market opportunities.

Report Scope:

In this report, the global contraceptive pills market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Market, By Pill Type:
  • Progestin Pills
  • Combination Pills
Market, By Category:
  • Generic
  • Branded
Market, By Sales Channel:
  • Offline
  • Online
Market, By Region:
  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Thailand
  • Rest of Asia-Pacific
  • Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Russia
  • Netherlands
  • Rest of Europe
  • North America
  • United States
  • Mexico
  • Canada
  • Rest of North America
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Rest of South America
  • Middle East & Africa
  • South Africa
  • UAE
  • Rest of Middle East & Africa
Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the global contraceptive pills market.

Available Customizations

With the given market data, customisation is offered for specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Profit Margin Analysis

Profit margin analysis in case of direct and indirect sales channel.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Allergan plc
  • Bayer AG
  • Church & Dwight Co., Inc.
  • Johnson & Johnson Limited
  • Merck & Co., Inc.
  • Mylan N.V.
  • MORE
1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customers/Customer Insights
4.1. Brand awareness (Aided & Unaided)
4.2. Sources of information
4.3. Preferred point of purchase
4.4. Factors influencing purchase decision

5. Global Contraceptive Pills Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Pill Type [Progestin Pills and Combination Pills]
5.2.2. By Category [Generic and Branded]
5.2.3. By Sales Channel [Offline and Online]
5.2.4. By Region [APAC, Europe, North America, South America & MEA]
5.2.5. By Company [2018]
5.3. Market Attractiveness Index [By Pill Type, By Category, By Sales Channel and By Region]

6. North America Contraceptive Pills Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Pill Type
6.2.2. By Category
6.2.3. By Sales Channel
6.2.4. By Country
6.3. United States Contraceptive Pills Market Outlook
6.3.1. Market Size & Forecast
6.3.1.1. By Value
6.3.2. Market Share & Forecast
6.3.2.1. By Pill Type
6.3.2.2. By Sales Channel
6.3.3. Pricing Analysis
6.4. Mexico Contraceptive Pills Market Outlook
6.4.1. Market Size & Forecast
6.4.1.1. By Value
6.4.2. Market Share & Forecast
6.4.2.1. By Pill Type
6.4.2.2. By Sales Channel
6.4.3. Pricing Analysis
6.5. Canada Contraceptive Pills Market Outlook
6.5.1. Market Size & Forecast
6.5.1.1. By Value
6.5.2. Market Share & Forecast
6.5.2.1. By Pill Type
6.5.2.2. By Sales Channel
6.5.3. Pricing Analysis

7. Europe Contraceptive Pills Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Pill Type
7.2.2. By Category
7.2.3. By Sales Channel
7.2.4. By Country
7.3. United Kingdom Contraceptive Pills Market Outlook
7.3.1. Market Size & Forecast
7.3.1.1. By Value
7.3.2. Market Share & Forecast
7.3.2.1. By Pill Type
7.3.2.2. By Sales Channel
7.3.3. Pricing Analysis
7.4. Germany Contraceptive Pills Market Outlook
7.4.1. Market Size & Forecast
7.4.1.1. By Value
7.4.2. Market Share & Forecast
7.4.2.1. By Pill Type
7.4.2.2. By Sales Channel
7.4.3. Pricing Analysis
7.5. France Contraceptive Pills Market Outlook
7.5.1. Market Size & Forecast
7.5.1.1. By Value
7.5.2. Market Share & Forecast
7.5.2.1. By Pill Type
7.5.2.2. By Sales Channel
7.5.3. Pricing Analysis
7.6. Italy Contraceptive Pills Market Outlook
7.6.1. Market Size & Forecast
7.6.1.1. By Value
7.6.2. Market Share & Forecast
7.6.2.1. By Pill Type
7.6.2.2. By Sales Channel
7.6.3. Pricing Analysis
7.7. Russia Contraceptive Pills Market Outlook
7.7.1. Market Size & Forecast
7.7.1.1. By Value
7.7.2. Market Share & Forecast
7.7.2.1. By Pill Type
7.7.2.2. By Sales Channel
7.7.3. Pricing Analysis
7.8. Netherlands Contraceptive Pills Market Outlook
7.8.1. Market Size & Forecast
7.8.1.1. By Value
7.8.2. Market Share & Forecast
7.8.2.1. By Pill Type
7.8.2.2. By Sales Channel
7.8.3. Pricing Analysis

8. Asia-Pacific Contraceptive Pills Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Pill Type
8.2.2. By Category
8.2.3. By Sales Channel
8.2.4. By Country
8.3. China Contraceptive Pills Market Outlook
8.3.1. Market Size & Forecast
8.3.1.1. By Value
8.3.2. Market Share & Forecast
8.3.2.1. By Pill Type
8.3.2.2. By Sales Channel
8.3.3. Pricing Analysis
8.4. India Contraceptive Pills Market Outlook
8.4.1. Market Size & Forecast
8.4.1.1. By Value
8.4.2. Market Share & Forecast
8.4.2.1. By Pill Type
8.4.2.2. By Sales Channel
8.4.3. Pricing Analysis
8.5. Japan Contraceptive Pills Market Outlook
8.5.1. Market Size & Forecast
8.5.1.1. By Value
8.5.2. Market Share & Forecast
8.5.2.1. By Pill Type
8.5.2.2. By Sales Channel
8.5.3. Pricing Analysis
8.6. Thailand Contraceptive Pills Market Outlook
8.6.1. Market Size & Forecast
8.6.1.1. By Value
8.6.2. Market Share & Forecast
8.6.2.1. By Pill Type
8.6.2.2. By Sales Channel
8.6.3. Pricing Analysis
8.7. Australia Contraceptive Pills Market Outlook
8.7.1. Market Size & Forecast
8.7.1.1. By Value
8.7.2. Market Share & Forecast
8.7.2.1. By Pill Type
8.7.2.2. By Sales Channel
8.7.3. Pricing Analysis

9. South America Contraceptive Pills Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Pill Type
9.2.2. By Category
9.2.3. By Sales Channel
9.2.4. By Country
9.3. Brazil Contraceptive Pills Market Outlook
9.3.1. Market Size & Forecast
9.3.1.1. By Value
9.3.2. Market Share & Forecast
9.3.2.1. By Pill Type
9.3.2.2. By Sales Channel
9.3.3. Pricing Analysis
9.4. Colombia Contraceptive Pills Market Outlook
9.4.1. Market Size & Forecast
9.4.1.1. By Value
9.4.2. Market Share & Forecast
9.4.2.1. By Pill Type
9.4.2.2. By Sales Channel
9.4.3. Pricing Analysis
9.5. Argentina Contraceptive Pills Market Outlook
9.5.1. Market Size & Forecast
9.5.1.1. By Value
9.5.2. Market Share & Forecast
9.5.2.1. By Pill Type
9.5.2.2. By Sales Channel
9.5.3. Pricing Analysis

10. Middle East and Africa Contraceptive Pills Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Pill Type
10.2.2. By Category
10.2.3. By Sales Channel
10.2.4. By Country
10.3. South Africa Contraceptive Pills Market Outlook
10.3.1. Market Size & Forecast
10.3.1.1. By Value
10.3.2. Market Share & Forecast
10.3.2.1. By Pill Type
10.3.2.2. By Sales Channel
10.3.3. Pricing Analysis
10.4. UAE Contraceptive Pills Market Outlook
10.4.1. Market Size & Forecast
10.4.1.1. By Value
10.4.2. Market Share & Forecast
10.4.2.1. By Pill Type
10.4.2.2. By Sales Channel
10.4.3. Pricing Analysis

11. Market Dynamics
11.1. Drivers/Opportunities
11.2. Challenges

12. Market Trends & Developments


13. Competitive Landscape
13.1. Competition Outlook
13.2. Company Profiles (Top 10 Companies)
13.2.1.1. Bayer AG
13.2.1.2. Allergan plc
13.2.1.3. Pfizer Inc.
13.2.1.4. Teva Pharmaceutical Industries Ltd.
13.2.1.5. Church & Dwight Co., Inc.
13.2.1.6. Johnson & Johnson Limited
13.2.1.7. Lupin Pharmaceuticals, Inc.
13.2.1.8. Merck & Co., Inc.
13.2.1.9. Mylan N.V.
13.2.1.10. Novartis International AG
(Note: The companies list can be customized based on the client requirements)

14. Strategic Recommendations
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Bayer AG
  • Allergan plc
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Church & Dwight Co., Inc.
  • Johnson & Johnson Limited
  • Lupin Pharmaceuticals, Inc.
  • Merck & Co., Inc.
  • Mylan N.V.
  • Novartis International AG
(Note: The companies list can be customized based on the client requirements)
Note: Product cover images may vary from those shown
Adroll
adroll